It looks like direct Medicare drug price negotiations are back in the U.S. fiscal 2022 budget bill. Nearly a week after President Joe Biden dropped drug pricing reforms from his Build Back Better budget framework, congressional Democrats came together on a scaled-back version of the pricing provisions originally included in H.R. 3.